Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Abivax (AAVXF) Operating Leases (2023 - 2025)

Historic Operating Leases for Abivax (AAVXF) over the last 3 years, with Q3 2025 value amounting to $2.9 million.

  • Abivax's Operating Leases changed N/A to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 27299.22% up from last year.
  • As of Q3 2025, Abivax's Operating Leases stood at $2.9 million.
  • Abivax's 5-year Operating Leases high stood at $2.9 million for Q3 2025, and its period low was $407781.2 during Q4 2023.
  • Over the past 3 years, Abivax's median Operating Leases value was $1.4 million (recorded in 2025), while the average stood at $1.5 million.
  • In the last 5 years, Abivax's Operating Leases surged by 27499.52% in 2024 and then tumbled by 4074.82% in 2025.
  • Over the past 3 years, Abivax's Operating Leases (Quarter) stood at $407781.2 in 2023, then surged by 275.0% to $1.5 million in 2024, then soared by 92.04% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $1.1 million for Q2 2025, and $1.3 million during Q1 2025.